A ciclesonide suspension nasal spray composition is disclosed, and the ciclesonide suspension nasal spray composition comprises ciclesonide monohydrate and a pharmaceutically acceptable carrier. The ciclesonide monohydrate is existed in a crystal form, and characteristic peaks are shown at diffraction angle 2*theta of 5.1 degrees, 9.0 degrees, 11.2 degrees, 12.8 degrees, 15.0 degrees, 16.2 degrees, 16.9 degrees and 20.7 degrees in X raypowderdiffraction.
The invention discloses a Ciclesonide medicinal water spray agant and its preparing process, wherein the constituents include (by weight portions): Ciclesonide 1 part, solvent 0.2-4 parts, emulsifying agent 0.04-4 parts, water 0.2-0.4 part. The process requires no casting agents such as CFC and HFC, thereby no pressure containers are needed.